Eric Eugene Boros
7Patents
4h-index
41Co-inventors
53Inventor score
Filing activity: Mar 11, 1999 → Jan 13, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7645771B2 | CCR5 antagonists as therapeutic agents | Human Necessities | 12 | Expired |
| US6177445A | Substituted isoquinolines as ultra short acting neuromuscular blockers | Chemistry; Metallurgy | 9 | Expired |
| US6187789A | Substituted isoquinolines as ultra short acting neuromuscular blockers | Chemistry; Metallurgy | 9 | Expired |
| US6110961A | Phenoxathin derivatives as inhibitors of monoamine oxidase | Human Necessities | 4 | Expired |
| US8691991B2 | 2-oxonaphthyridine-3-carboxamides HIV integrase inhibitors | Human Necessities | 2 | Active |
| US7189851B2 | Condensed heterocyclic compounds as calcitonin agonists | Chemistry; Metallurgy | 0 | Expired |
| US8222261B2 | Chemical compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.